| Record Information |
| Version |
3.5 |
| Creation Date |
2006-05-22 09:12:02 -0600 |
| Update Date |
2013-02-08 17:12:03 -0700 |
| HMDB ID |
HMDB02670 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Naringenin |
| Description |
Naringenin (not to be confused with naringin) is a flavanone that is considered to have a bioactive effect on human health as antioxidant, free radical scavenger, antiinflammatory, carbohydrate metabolism promoter, immunity system modulater. This substance has also been shown to repair DNA. Scientists exposed cells to 80 micomoles of naringenin per liter, for 24 hours, and found that the amount of hydroxyl damage to the DNA was reduced by 24 percent in that very short period of time. Unfortunately, this bioflavonoid is difficult to absorb on oral ingestion. Only 15% of ingested naringenin will get absorbed, in the human gastrointestinal tract, in the best case scenario. A full glass of orange juice will supply about enough naringenin to achieve a concentration of about 0.5 micromoles per liter. But, one has to wonder, if given more time than 24 hours, would lower concentrations have similar effects. Wikipedia. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (-)-Naringenin
- Asahina
- Naringenin
- Naringenine
- Naringetol
- Pelargidanon
- Salipurol
- Salipurpol
|
| Chemical Formula |
C15H12O5 |
| Average Molecular Weight |
272.2528 |
| Monoisotopic Molecular Weight |
272.068473494 |
| IUPAC Name |
(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one |
| Traditional IUPAC Name |
naringenin |
| CAS Registry Number |
480-41-1 |
| SMILES |
OC1=CC=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1 |
| InChI Identifier |
InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2/t13-/m0/s1 |
| InChI Key |
FTVWIRXFELQLPI-ZDUSSCGKSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aromatic Heteropolycyclic Compounds |
| Class |
Flavonoids |
| Sub Class |
Flavans |
| Other Descriptors |
- Aromatic Heteropolycyclic Compounds
- Flavanones(KEGG)
- Flavanones(Lipidmaps)
- naringenin(ChEBI)
|
| Substituents |
- Alkyl Aryl Ether
- Benzopyran
- Chromane
- Ketone
- Phenol
- Phenol Derivative
- Pyran
- Resorcinol
|
| Direct Parent |
Flavanones |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- anti-allergic
- anti-inflammatory
- anti-proliferative
- pro-oxidant
|
| Application |
|
| Cellular locations |
- Membrane (predicted from logP)
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
251 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
2.52 |
PERRISSOUD,D & TESTA,B (1986) |
|
| Predicted Properties |
|
| Spectra |
|
| 1H NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies ) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies ) |
| MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 5 |
| MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 5 |
| MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) |
| MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) |
| MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) |
| MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
- Membrane (predicted from logP)
|
| Biofluid Locations |
|
| Tissue Location |
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.02 +/- 0.05 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Urine |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Urine |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Urine |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Urine |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Urine |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Urine |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Urine |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Urine |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Consuming polyphenols described by Phenol-Explorer entry 201 |
Not Available |
| Urine |
Detected and Quantified |
|
410 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
24 hours after the 2-day diet started
|
| Urine |
Detected and Quantified |
|
560 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
After 2-day diet protocol
|
| Urine |
Detected and Quantified |
|
0.0065 +/- 0.013 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.032 +/- 0.032 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.019 +/- 0.013 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.019 +/- 0.026 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.0 +/- 0.0065 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.62 +/- 0.82 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.55 +/- 0.20 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
201  |
| Phenol Explorer Metabolite ID |
201  |
| FoodDB ID |
FDB000678 |
| KNApSAcK ID |
C00000982  |
| Chemspider ID |
388383  |
| KEGG Compound ID |
C00509  |
| BioCyc ID |
CPD-3161  |
| BiGG ID |
Not Available |
| Wikipedia Link |
Naringenin  |
| NuGOwiki Link |
HMDB02670  |
| Metagene Link |
HMDB02670  |
| METLIN ID |
3401  |
| PubChem Compound |
439246  |
| PDB ID |
NAR  |
| ChEBI ID |
17846  |
| References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Walker D, Flinois JP, Monkman SC, Beloc C, Boddy AV, Cholerton S, Daly AK, Lind MJ, Pearson AD, Beaune PH, et al.: Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide. Biochem Pharmacol. 1994 Mar 29;47(7):1157-63.
Pubmed: 8161344
- Ameer B, Weintraub RA, Johnson JV, Yost RA, Rouseff RL: Flavanone absorption after naringin, hesperidin, and citrus administration. Clin Pharmacol Ther. 1996 Jul;60(1):34-40.
Pubmed: 8689809
- Kanaze FI, Kokkalou E, Georgarakis M, Niopas I: Validated high-performance liquid chromatographic method utilizing solid-phase extraction for the simultaneous determination of naringenin and hesperetin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Mar 5;801(2):363-7.
Pubmed: 14751808
- Guengerich FP, Kim DH: In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis. 1990 Dec;11(12):2275-9.
Pubmed: 2265479
- Ishii K, Furuta T, Kasuya Y: Determination of naringin and naringenin in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl. 1996 Aug 30;683(2):225-9.
Pubmed: 8891919
- Matsuo M, Sasaki N, Saga K, Kaneko T: Cytotoxicity of flavonoids toward cultured normal human cells. Biol Pharm Bull. 2005 Feb;28(2):253-9.
Pubmed: 15684479
- Franke AA, Cooney RV, Henning SM, Custer LJ: Bioavailability and antioxidant effects of orange juice components in humans. J Agric Food Chem. 2005 Jun 29;53(13):5170-8.
Pubmed: 15969493
- Fuhr U, Kummert AL: The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin Pharmacol Ther. 1995 Oct;58(4):365-73.
Pubmed: 7586927
- Miniscalco A, Lundahl J, Regardh CG, Edgar B, Eriksson UG: Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther. 1992 Jun;261(3):1195-9.
Pubmed: 1602384
- Lin YT, Hsiu SL, Hou YC, Chen HY, Chao PD: Degradation of flavonoid aglycones by rabbit, rat and human fecal flora. Biol Pharm Bull. 2003 May;26(5):747-51.
Pubmed: 12736527
- Malaveille C, Hautefeuille A, Pignatelli B, Talaska G, Vineis P, Bartsch H: Dietary phenolics as anti-mutagens and inhibitors of tobacco-related DNA adduction in the urothelium of smokers. Carcinogenesis. 1996 Oct;17(10):2193-200.
Pubmed: 8895488
|